about
Ternary copper complexes for photocleavage of DNA by red light: direct evidence for sulfur-to-copper charge transfer and d-d band involvement.Metal-assisted red light-induced efficient DNA cleavage by dipyridoquinoxaline-copper(II) complex.Designing molecules for PDT: red light-induced DNA cleavage on disulfide bond activation in a dicopper(II) complex.DNA cleavage on photoexposure at the d-d band in ternary copper(II) complexes using red-light laser.Photosensitizer in a molecular bowl and its effect on the DNA-binding and -cleavage activity of 3d-metal scorpionates.In vivo imaging with a cell-permeable porphyrin-based MRI contrast agent.Efficient visible light induced nuclease activity of a ternary mono-1,10-phenanthroline copper(II) complex containing 2-(methylthio)ethylsalicylaldimine.Visible light-induced nuclease activity of a ternary mono-phenanthroline copper(II) complex containing L-methionine as a photosensitizer.Bis(dipyridophenazine)copper(II) complex as major groove directing synthetic hydrolase.Synthetic analogue approach for the functional domains of copper(II) bleomycins and its DNA cleavage activity.Ternary iron(II) complex with an emissive imidazopyridine arm from Schiff base cyclizations and its oxidative DNA cleavage activity.Metal-assisted red light-induced DNA cleavage by ternary L-methionine copper(II) complexes of planar heterocyclic bases.Photosensitizer in a molecular bowl: steric protection enhancing the photonuclease activity of copper(II) scorpionates.Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution.Reduction of cisplatin induced ototoxicity without compromising its antitumor activityTargeted Mitochondrial COQ Delivery Attenuates Antiretroviral-Drug-Induced Senescence of Neural Progenitor CellsSynthesis and characterization of {Ni(NO)}10 and {Co(NO)2}10 complexes supported by thiolate ligands.Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotectionOrally Administrable Therapeutic Synthetic Nanoparticle for Zika VirusDual-Targeted Synthetic Nanoparticles for Cardiovascular Diseases
P50
Q30744775-80EC8303-930D-49CA-BFD0-56D876A4029FQ31020238-C84281D9-1002-4D77-A0DD-A0F7D0131585Q31136917-04C5AC98-3AB4-4F99-BB4F-CC37B1C08599Q33266802-1AAB76A4-F78B-4F9C-917A-8F2F28648B78Q33340759-12A63654-2BBA-4F8C-969D-BCC90E9F0749Q42725710-2E62AB9B-8F1A-4E65-8D3A-CEDE85A2605BQ44400789-F9A847CA-78EF-42BF-B64C-972ADF651D92Q44516972-1CF52EF9-0613-4012-8E4D-11AB830FF7A5Q45069942-E9779A18-AF3A-4E39-9F33-6FACE8FC2DC6Q45169213-1CF3843F-42DA-4484-9719-87EF0DDC6F36Q45199624-68C233DA-7DBB-4FF8-AF66-4579BDD3C28CQ45278952-3C9EAB6D-24F2-4FF6-83D8-8A1E50CD6E18Q46428841-573E2FEF-6DE5-444E-8D8D-8DEA90038605Q50018257-BA0E4A07-142E-4A80-8537-35CE86CCD39FQ57033863-8B343944-4884-4542-A5CC-53A51C521BD6Q61812140-BAA173C4-4864-4905-A281-3A2A2C9129D1Q64914885-800BA799-F2E5-4E44-9439-2A6A05300B8AQ90365136-FF07398C-3AD2-4BF2-A9C1-69813B3857F2Q90650906-309BB49E-ED1F-4F16-AA66-E6B123651222Q92316657-B725245B-33E8-4586-82A8-645E9A1A1C54
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Shanta Dhar
@ast
Shanta Dhar
@en
Shanta Dhar
@es
Shanta Dhar
@nl
Shanta Dhar
@sl
type
label
Shanta Dhar
@ast
Shanta Dhar
@en
Shanta Dhar
@es
Shanta Dhar
@nl
Shanta Dhar
@sl
prefLabel
Shanta Dhar
@ast
Shanta Dhar
@en
Shanta Dhar
@es
Shanta Dhar
@nl
Shanta Dhar
@sl
P106
P31
P496
0000-0003-3042-5272